547 related articles for article (PubMed ID: 24798001)
21. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
[TBL] [Abstract][Full Text] [Related]
23. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
24. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.
Zhou SL; Zhou ZJ; Hu ZQ; Song CL; Luo YJ; Luo CB; Xin HY; Yang XR; Shi YH; Wang Z; Huang XW; Cao Y; Fan J; Zhou J
J Hepatol; 2019 Dec; 71(6):1152-1163. PubMed ID: 31349001
[TBL] [Abstract][Full Text] [Related]
25. New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatment.
Vilarinho S; Calvisi DF
Hepatology; 2014 Dec; 60(6):1812-4. PubMed ID: 25042754
[No Abstract] [Full Text] [Related]
26. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
[TBL] [Abstract][Full Text] [Related]
27. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.
Khemlina G; Ikeda S; Kurzrock R
Mol Cancer; 2017 Aug; 16(1):149. PubMed ID: 28854942
[TBL] [Abstract][Full Text] [Related]
28. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
[TBL] [Abstract][Full Text] [Related]
29. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
Takada Y; Otsuka M; Todoroki T; Fukao K
Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
[TBL] [Abstract][Full Text] [Related]
30. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
31. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D
Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338
[TBL] [Abstract][Full Text] [Related]
32. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.
Katoh H; Shibata T; Kokubu A; Ojima H; Loukopoulos P; Kanai Y; Kosuge T; Fukayama M; Kondo T; Sakamoto M; Hosoda F; Ohki M; Imoto I; Inazawa J; Hirohashi S
J Hepatol; 2005 Nov; 43(5):863-74. PubMed ID: 16139920
[TBL] [Abstract][Full Text] [Related]
33. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
34. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
[TBL] [Abstract][Full Text] [Related]
35. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
36. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.
Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J
Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832
[TBL] [Abstract][Full Text] [Related]
37. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.
Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp AC; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2015 Mar; 100(3):E493-502. PubMed ID: 25490274
[TBL] [Abstract][Full Text] [Related]
38. Reply: To PMID 24798001.
Haq F; Ahn SM
Hepatology; 2015 Oct; 62(4):1324-5. PubMed ID: 25677638
[No Abstract] [Full Text] [Related]
39. Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma.
Yoon SO; Chun SM; Han EH; Choi J; Jang SJ; Koh SA; Hwang S; Yu E
Hum Pathol; 2011 Oct; 42(10):1391-400. PubMed ID: 21458843
[TBL] [Abstract][Full Text] [Related]
40. Genetics of hepatocellular tumors.
Laurent-Puig P; Zucman-Rossi J
Oncogene; 2006 Jun; 25(27):3778-86. PubMed ID: 16799619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
